Replies to post #622816 on NorthWest Biotherapeutics Inc (NWBO)

[hankmanhub]

And most of the 1300 were never treated with DCVAX-L.

[iclight]

so really the number one should be concerned about is the survival of the 332 trial enrollees.

Not when the same screening process isn't used for the ECA. Which of course don't even have patient level data.

Hell, there's not patient level data for the 332 either. Or at least the company is mum on that. Gee, wonder why?